Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tate & Lyle Plc (TATE.LN)

Tate & Lyle Plc (TATE.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,562,410
  • Shares Outstanding, K 383,977
  • Annual Sales, $ 1,647 M
  • Annual Income, $ 188,000 K
  • 60-Month Beta N/A
  • Price/Sales 1.63
  • Price/Cash Flow 13.02
  • Price/Book 2.07
Trade TATE.LN with:
  • Price/Earnings ttm 15.09
  • Earnings Per Share ttm 0.47
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.19 (2.85%)
  • Most Recent Dividend 0.129 on 06/20/24
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
637.500 +4.39%
on 08/22/24
697.000 -4.52%
on 09/10/24
+13.000 (+1.99%)
since 08/16/24
3-Month
590.000 +12.80%
on 07/03/24
697.000 -4.52%
on 09/10/24
-14.500 (-2.13%)
since 06/18/24
52-Week
587.000 +13.37%
on 03/08/24
731.500 -9.02%
on 06/03/24
-31.500 (-4.52%)
since 09/18/23

Most Recent Stories

More News
Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyle's Stevia and Allulose Production

REDWOOD CITY, Calif. and HOFFMANN ESTATES, Ill., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Tate...

TATE.LN : 665.500 (-0.67%)
CDXS : 3.11 (-1.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 699.333
2nd Resistance Point 692.167
1st Resistance Point 678.833
Last Price 665.500
1st Support Level 658.333
2nd Support Level 651.167
3rd Support Level 637.833

See More

52-Week High 731.500
Fibonacci 61.8% 676.301
Last Price 665.500
Fibonacci 50% 659.250
Fibonacci 38.2% 642.199
52-Week Low 587.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar